These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33080378)

  • 1. Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders.
    Zinzow H; Shi L; Rennert L; Chen L; Lopes S; Zhang L; Jones K; Jindal M; Stam C; Mclain M
    Contemp Clin Trials; 2020 Dec; 99():106182. PubMed ID: 33080378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
    Bowen S; Witkiewitz K; Clifasefi SL; Grow J; Chawla N; Hsu SH; Carroll HA; Harrop E; Collins SE; Lustyk MK; Larimer ME
    JAMA Psychiatry; 2014 May; 71(5):547-56. PubMed ID: 24647726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial.
    Brady KT; Killeen T; Baker NL
    Contemp Clin Trials; 2021 Jun; 105():106393. PubMed ID: 33857680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mindfulness-based relapse prevention in a sample of veterans in a substance use disorder aftercare program: A randomized controlled trial.
    Killeen TK; Baker NL; Davis LL; Bowen S; Brady KT
    J Subst Use Addict Treat; 2023 Sep; 152():209116. PubMed ID: 37364669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial.
    Davis JP; Berry D; Dumas TM; Ritter E; Smith DC; Menard C; Roberts BW
    J Subst Abuse Treat; 2018 Aug; 91():37-48. PubMed ID: 29910013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness practice moderates the relationship between craving and substance use in a clinical sample.
    Enkema MC; Bowen S
    Drug Alcohol Depend; 2017 Oct; 179():1-7. PubMed ID: 28734167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial.
    Somohano VC; Bowen S
    J Integr Complement Med; 2022 Sep; 28(9):729-738. PubMed ID: 35648046
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
    Witkiewitz K; Lustyk MKB; Bowen S
    Psychol Addict Behav; 2013 Jun; 27(2):351-365. PubMed ID: 22775773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Mindfulness-Based Relapse Prevention Program as an Adjunct to the Standard Treatment for Smoking: A Pragmatic Design Pilot Study.
    Weiss de Souza IC; Kozasa EH; Bowen S; Richter KP; Sartes LMA; Colugnati FAB; Noto AR
    Nicotine Tob Res; 2020 Aug; 22(9):1605-1613. PubMed ID: 32222767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
    Witkiewitz K; Bowen S
    J Consult Clin Psychol; 2010 Jun; 78(3):362-374. PubMed ID: 20515211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial.
    Schneegans A; Bourgognon F; Albuisson E; Schwan R; Arfa M; Polli L; Moulard M; Laprévote V; Schwitzer T
    Encephale; 2022 Jun; 48(3):241-246. PubMed ID: 34092381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.
    Roos CR; Bowen S; Witkiewitz K
    J Consult Clin Psychol; 2017 Nov; 85(11):1041-1051. PubMed ID: 29083220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mindfulness-based relapse prevention for substance craving.
    Witkiewitz K; Bowen S; Douglas H; Hsu SH
    Addict Behav; 2013 Feb; 38(2):1563-1571. PubMed ID: 22534451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnicity and racial group composition moderate the effectiveness of mindfulness-based relapse prevention for substance use disorder.
    Greenfield BL; Roos C; Hagler KJ; Stein E; Bowen S; Witkiewitz KA
    Addict Behav; 2018 Jun; 81():96-103. PubMed ID: 29454179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study.
    Zullig KJ; Lander LR; Tuscano M; Garland M; Hobbs GR; Faulkenberry L
    Mindfulness (N Y); 2021; 12(12):3036-3046. PubMed ID: 34659584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enactment of home practice following mindfulness-based relapse prevention and its association with substance-use outcomes.
    Grow JC; Collins SE; Harrop EN; Marlatt GA
    Addict Behav; 2015 Jan; 40():16-20. PubMed ID: 25218066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.
    Bowen S; Chawla N; Collins SE; Witkiewitz K; Hsu S; Grow J; Clifasefi S; Garner M; Douglass A; Larimer ME; Marlatt A
    Subst Abus; 2009; 30(4):295-305. PubMed ID: 19904665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, acceptability and preliminary outcomes of a mindfulness-based relapse prevention program in a naturalistic setting among treatment-seeking patients with alcohol use disorder: a prospective observational study.
    von Hammerstein C; Khazaal Y; Dupuis M; Aubin HJ; Benyamina A; Luquiens A; Romo L
    BMJ Open; 2019 Jun; 9(5):e026839. PubMed ID: 31154307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.